Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials

Munveer Thind*, Harry J. Crijns, Gerald V. Naccarelli, James A. Reiffel, Valerie Corp Dit Genti, Mattias Wieloch, Andrew Koren, Peter R. Kowey

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1022-1030
Number of pages9
JournalJournal of Cardiovascular Electrophysiology
Volume31
Issue number5
DOIs
Publication statusPublished - May 2020

Keywords

  • antiarrhythmic drug
  • atrial fibrillation
  • atrial flutter
  • cardioversion
  • dronedarone
  • ACC/AHA/ESC 2006 GUIDELINES
  • ASSOCIATION TASK-FORCE
  • EURO HEART SURVEY
  • SINUS RHYTHM
  • AMERICAN-COLLEGE
  • RISK-FACTORS
  • MANAGEMENT
  • EFFICACY
  • MAINTENANCE
  • DOFETILIDE

Cite this